000705.SHE Zhejiang Zhenyuan Share Co Ltd
- Market cap
- CNY 2.08B
- P/E
- -
- P/B
- 1.06x
- ROE
- -3.2%
- Dividend yield
- 1.30%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 000705.SHE undervalued?
Graham numberThe Graham number of Zhejiang Zhenyuan Share Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Zhenyuan Share Co Ltd fundamental analysis
No fundamental analysis for Zhejiang Zhenyuan Share Co Ltd yet.
Zhejiang Zhenyuan Share Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Zhenyuan Share Co Ltd
Zhejiang Zhenyuan Share Co.,Ltd. engages in the production and operation of pharmaceutical products in China and internationally. It offers chinese medicinal herbs, processed chinese medicinal herbs, prepared chinese medicines, and chemical raw materials. The company also provides pharmaceutical logistics, health services, etc., as well as engages in the wholesale and retail of pharmaceutical products, pre-packaged food, and bulk food and dairy products. It sells its pharmac…
Full company profileZhejiang Zhenyuan Share Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhejiang Zhenyuan Share Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.44B | 2.58B | 2.86B | 3.24B | 3.44B | 3.61B | 4.15B | 4.11B | 3.74B | 2.28B | 1.73B |
| Gross Profit | 343M | 420M | 581M | 683M | 730M | 703M | 749M | 763M | 693M | 567M | 389M |
| Operating Income | 58.6M | 79.1M | 86.6M | 258M | 117M | 106M | 105M | 113M | 55.9M | 14.3M | 1.28M |
| EBITDA | 109M | 133M | 144M | 312M | 170M | 165M | 166M | 176M | 122M | 144M | -39.4M |
| Net Income | 45.3M | 61.1M | 70.9M | 212M | 89.4M | 77.3M | 77.9M | 81.6M | 34.7M | 22.7M | -60.1M |
| EPS | 0.14 | 0.18 | 0.21 | 0.63 | 0.27 | 0.23 | 0.23 | 0.24 | 0.10 | 0.07 | -0.18 |
| Balance Sheet | |||||||||||
| Total Assets | 2.02B | 2.05B | 2.12B | 2.59B | 2.70B | 2.99B | 3.23B | 2.94B | 3.42B | 2.93B | 2.87B |
| Total Liabilities | 703M | 662M | 677M | 877M | 939M | 1.11B | 1.28B | 940M | 1.46B | 953M | 961M |
| Shareholders' Equity | 1.29B | 1.37B | 1.42B | 1.69B | 1.74B | 1.85B | 1.92B | 1.98B | 1.96B | 1.98B | 1.91B |
| Cash & Short-term Investments | 246M | 236M | 216M | 541M | 660M | 634M | 453M | 459M | 549M | 435M | 499M |
| Total Debt | 60.5M | 30.0M | 30.0M | 97.6M | 50.0M | 82.9M | 81.2M | 55.0M | 414M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 116M | 51.7M | 25.5M | 118M | 155M | 75.2M | -20.1M | 90.8M | 76.1M | 40.6M | - |
| Capital Expenditure | 43.0M | 37.6M | 48.9M | 87.5M | 42.2M | 71.2M | 104M | 194M | 331M | 186M | 134M |
| Free Cash Flow | 73.0M | 14.1M | -23.4M | 30.8M | 113M | 3.97M | -124M | -102M | -255M | -146M | 81.2M |
| Ratios | |||||||||||
| ROE | 3.5% | 4.5% | 5.0% | 12.5% | 5.1% | 4.2% | 4.1% | 4.1% | 1.8% | 1.1% | -3.2% |
| ROA | 2.2% | 3.0% | 3.3% | 8.2% | 3.3% | 2.6% | 2.4% | 2.8% | 1.0% | 0.8% | -2.1% |
| Net Profit Margin | 1.9% | 2.4% | 2.5% | 6.5% | 2.6% | 2.1% | 1.9% | 2.0% | 0.9% | 1.0% | -3.5% |
| Debt to Equity | 0.05x | 0.02x | 0.02x | 0.06x | 0.03x | 0.04x | 0.04x | 0.03x | 0.21x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhejiang Zhenyuan Share Co Ltd dividends
- Dividend yield
- 1.30%
- Forward dividend
- -
- Payout ratio
- 119.3%
- Ex-dividend date
- Jun 27, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 27.1M | 0.08 | 119.3% |
| 2024 | CNY 23.9M | 0.07 | 68.8% |
| 2023 | CNY 20.0M | 0.06 | 24.6% |
| 2022 | CNY 20.5M | 0.06 | 26.3% |
| 2021 | CNY 23.4M | 0.07 | 30.3% |
| 2020 | CNY 20.0M | 0.06 | 22.4% |
| 2019 | CNY 10.0M | 0.03 | 4.7% |
| 2018 | CNY 1.53M | 0.00 | 2.2% |
| 2017 | CNY 8.38M | 0.02 | 13.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on Aug 27, 2014.
Who owns Zhejiang Zhenyuan Share Co Ltd
- Insiders 29.32%
- Institutions 1.60%
- Public & others 69.08%
- Shares outstanding 334M
- Free float 249M
Zhejiang Zhenyuan Share Co Ltd company profile
- Company name
- Zhejiang Zhenyuan Share Co Ltd
- Ticker
- 000705.SHE
- ISIN
- CNE0000007L4
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Mar 20, 1997
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 1,887
- Fiscal year end
- December
- Address
- No. 558, Yan'an East Road, Shaoxing, China, 312000
- Phone
- 86 575 8514 4121
- Website
- zjzy.com
About Zhejiang Zhenyuan Share Co Ltd
Zhejiang Zhenyuan Share Co.,Ltd. engages in the production and operation of pharmaceutical products in China and internationally. It offers chinese medicinal herbs, processed chinese medicinal herbs, prepared chinese medicines, and chemical raw materials. The company also provides pharmaceutical logistics, health services, etc., as well as engages in the wholesale and retail of pharmaceutical products, pre-packaged food, and bulk food and dairy products. It sells its pharmaceutical products through online and offline channels. The company was founded in 1993 and is based in Shaoxing, China.
Zhejiang Zhenyuan Share Co Ltd management
6- Mr. Zhang BinChief Financial Officer · born 1986
- Mr. Hao WangDeputy GM & Director · born 1974
- Mr. Yuhua LouDirector & Deputy General Manager · born 1978
- Ms. Zhanyi QianDirector & Deputy GM · born 1982
- Mr. Yufeng ZhangBoard Secretary · born 1984
- Yeqian GuAccounting Supervisor